David Mountcastle Sells 23,887 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 23,887 shares of the stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $25.03, for a total value of $597,891.61. Following the sale, the chief financial officer directly owned 172,909 shares in the company, valued at $4,327,912.27. This trade represents a 12.14% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Privia Health Group Price Performance

NASDAQ:PRVA traded down $0.53 during trading hours on Tuesday, hitting $23.81. The stock had a trading volume of 814,953 shares, compared to its average volume of 833,471. The company has a 50 day simple moving average of $24.45 and a two-hundred day simple moving average of $22.80. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of 183.17, a P/E/G ratio of 4.30 and a beta of 0.83. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The company had revenue of $213.61 million for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. Equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on PRVA shares. Evercore ISI upped their price objective on Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Stephens restated an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Thursday, December 4th. Canaccord Genuity Group increased their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research note on Monday. Finally, Truist Financial restated a “buy” rating and issued a $31.00 price objective (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.42.

Institutional Trading of Privia Health Group

Institutional investors have recently made changes to their positions in the stock. Russell Investments Group Ltd. grew its holdings in shares of Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares during the last quarter. CWM LLC boosted its position in Privia Health Group by 89.4% during the 2nd quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after buying an additional 1,612 shares during the period. Canada Pension Plan Investment Board grew its holdings in Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after acquiring an additional 1,200 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Privia Health Group in the second quarter valued at about $113,000. Finally, Covestor Ltd increased its position in shares of Privia Health Group by 39.8% in the third quarter. Covestor Ltd now owns 5,824 shares of the company’s stock valued at $145,000 after acquiring an additional 1,657 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.